Ask For a Blood test to identify AR-V7 in Circulating Tumor Cells if you are starting Xtandi or Zytiga

One of the hot topics in the prostate cancer community is the value of detecting AR-V7 tumor cells circulating in the blood. AR-V7 tumor cells in the blood predicts response or failure of┬átreatment with enzalutamide (Xtandi) or abiraterone (Zytiga). A┬árecent study found that men who have AR-V7 circulating tumor cells in their blood will not … Continue reading Ask For a Blood test to identify AR-V7 in Circulating Tumor Cells if you are starting Xtandi or Zytiga